Company Overview and News

0
HCOM / Hawaiian Telcom Holdco, Inc. 15-12B

2018-07-12 sec.gov
15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
HCOM

6
Telecom Stock Roundup: Verizon Go90 Pullout, China Mobile's US Entry Block & More

2018-07-05 zacks
In the last five trading days, telecom stocks witnessed a sharp rise initially as China eased some foreign investment curbs but fell slightly thereafter to maintain a flat trajectory. The stocks regained the lost ground later in the week due to temporary relief to ZTE to resume some business activities. Amid the looming trade war tensions between the United States and China, the communist nation took a positive step toward easing the limits on foreign ownership in some of its closely guarded sectors.
HCOM DB CHLKF DLPH VZA T 0941 MSI CBB CHL VZ QCOM SBAC CBB.PRB TU

2
Cincinnati Bell Completes Acquisition of Hawaiian Telcom

2018-07-03 zacks
Cincinnati Bell Inc. (CBB - Free Report) recently announced that it has completed the acquisition of Hawaiian Telcom Holdco, Inc. . The financial terms of the deal remained undisclosed. Headquartered in Honolulu, Hawaiian Telcom is Hawai‘i’s fiber-centric technology leader and provides integrated communications, broadband, data center and entertainment solutions for business and residential customers.
CBB HCOM BLT UGI BHP BHPBF BBL ATO BHP BHPLF CBB.PRB

2
HCOM / Hawaiian Telcom Holdco, Inc. S-8 POS

2018-07-02 sec.gov
As filed with the Securities and Exchange Commission on July 2, 2018
HCOM

259
Stocks To Watch: Tariffs Don't Take Holidays

2018-06-30 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. As usual, a new quarter and the second half of the trading year will begin with a shortened week due to the Independence Day holiday -- a "trading week interruptus," with July 4 landing on Wednesday.
TCBK FBIP TCYSF SIRI ISCA 1128 MT CUKPF FNBG GM.WS.A GM.WS.B GM.WS.C 1928 CBB.PRB NCMI TRBAB AYI SRRK GSKY TRBNW CCL CUK SHERF PSMT MLHR KNSA QCOM FCAU SJMHF GM.WSB PFE SBGI MT RCH SSNLF TM LSXMA NXPI CLPS ZGNX AYI.WI SJMHY MLCO ISCB CCL GM EVOP DIS HCOM F CSTM CMCSA SCHYF CSTM WYNMF LLY MGTX HMC 0880 CBB ITRM BHVN VC RHUHF SIFY 506186 FGEN GLXYENT BHR SNE SCHYY TRCO WYNMY

43
Telecom Stock Roundup: VZ Reality Ad Launch, CBB's Merger Deal & More

2018-06-21 zacks
In the last five trading days, telecom stocks flattered to deceive as the initial upturn was replaced by a persistent downturn for the most part of the past week as President Trump renewed fears of a fresh trade war with China. The on-again off-again trade war between the United States and China took a new turn when Trump imposed a fresh salvo of tariffs worth $50 billion on Chinese imports last week.
MSI CBB HCOM VZ NOKIA NOK HRS QCOM CBB.PRB VZA

20
Cincinnati Bell Wins FCC Approval to Acquire Hawaiian Telcom

2018-06-20 zacks
Cincinnati Bell Inc. (CBB - Free Report) recently announced that it has received final regulatory approval from the U.S. Federal Communications Commission (“FCC”) to acquire Hawaiian Telcom Holdco, Inc. . The transaction is now subject to the satisfaction of customary closing conditions. Headquartered in Honolulu, Hawaiian Telcom is Hawai‘i’s technology leader. The company provides integrated communications, broadband, data center and entertainment solutions for business and residential customers.
CBB HCOM UGI ATO CBB.PRB

7
ECA2018-110 - Information Regarding the Merger of Hawaiian Telcom Holdco, Inc. (HCOM)

2018-06-20 nasdaqtrader
At a special meeting held on November 7, 2017, the shareholders of Hawaiian Telcom Holdco, Inc. (HCOM) approved a merger with Cincinnati Bell Inc. (NYSE: CBB). The anticipated closing date is July 2, 2018. The details are as follows:
CBB HCOM CBB.PRB

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to HCOM / Hawaiian Telcom Holdco, Inc. on message board site Silicon Investor.

HCOM - HomeCom Communications u003c Short Term Gain? u003e
CUSIP: 420031106